Literature DB >> 28526235

Zero echo time MRI-only treatment planning for radiation therapy of brain tumors after resection.

C Boydev1, B Demol2, D Pasquier3, H Saint-Jalmes4, G Delpon5, N Reynaert3.   

Abstract

Using magnetic resonance imaging (MRI) as the sole imaging modality for patient modeling in radiation therapy (RT) is a challenging task due to the need to derive electron density information from MRI and construct a so-called pseudo-computed tomography (pCT) image. We have previously published a new method to derive pCT images from head T1-weighted (T1-w) MR images using a single-atlas propagation scheme followed by a post hoc correction of the mapped CT numbers using local intensity information. The purpose of this study was to investigate the performance of our method with head zero echo time (ZTE) MR images. To evaluate results, the mean absolute error in bins of 20 HU was calculated with respect to the true planning CT scan of the patient. We demonstrated that applying our method using ZTE MR images instead of T1-w improved the correctness of the pCT in case of bone resection surgery prior to RT (that is, an example of large anatomical difference between the atlas and the patient).
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Atlas-based method; Head cancer; MRI-only treatment planning; Pseudo-CT; ZTE sequence

Mesh:

Year:  2017        PMID: 28526235     DOI: 10.1016/j.ejmp.2017.04.028

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  2 in total

1.  Assessing the impact of choosing different deformable registration algorithms on cone-beam CT enhancement by histogram matching.

Authors:  Halima Saadia Kidar; Hacene Azizi
Journal:  Radiat Oncol       Date:  2018-11-07       Impact factor: 3.481

2.  Characteristics of the Exradin W1 scintillator in the magnetic field.

Authors:  Jeongmin Yoon; Jung-In Kim; Chang Heon Choi; Jong Min Park
Journal:  J Appl Clin Med Phys       Date:  2019-08-28       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.